MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 9, 2005; DOI: 10.1124/mol.105.021535


This Article
Right arrow Full Text (PDF)
Right arrow Related Article
Right arrow All Versions of this Article:
mol.105.021535v1
69/3/673    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neve, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neve, K. A.


Received for publication December 7, 2005.
Revised December 8, 2005.
Accepted for publication December 9, 2005.

Novel Features of G Protein-Coupled Receptor Kinase 4 (Relates to Article by Rankin, et al. FastForward 7 December 2005)

Kim A. Neve 1*

1 VA Medical Center

* Address correspondence to: E-mail: nevek{at}ohsu.edu

Abstract

The defining characteristic of G protein-coupled receptor homologous desensitization is that the receptor must be occupied by an agonist or in an activated conformation that mimics an agonist-induced state. In most instances, the mechanistic basis for this characteristic is the high selectivity of G protein-coupled receptor kinases for the activated receptor. Rankin et al. (p. XXX) now demonstrate that under at least some conditions the G protein-coupled receptor kinase GRK4 does not display a preference for the agonist-occupied D1 dopamine receptor. Co-expression of GRK4 and the D1 receptor in a heterologous system induces phosphorylation of the receptor in the absence of agonist, causing constitutive desensitization and internalization of the receptor. Lacking the normal rapid feedback mechanisms associated with homologous desensitization, a system incorporating constitutively active GRK4 will be prone to dysregulation, perhaps explaining the generally low expression of GRK4. Indeed, considerable evidence suggests that just such dysregulation resulting from mutationally activated GRK4 contributes to the heritable component of human essential hypertension (Physiol Genomics 19:223-246, 2004).


Key words: Dopamine, Protein Kinases (other), GRKs, barrestins, Phosphorylation/Dephosphorylation


This article has been cited by other articles:


Home page
HypertensionHome page
S. Hasenkamp, R. Telgmann, J. A. Staessen, C. Hagedorn, C. Dordelmann, M. Bek, S.-M. Brand-Herrmann, and E. Brand
Characterization and Functional Analyses of the Human G Protein-Coupled Receptor Kinase 4 Gene Promoter
Hypertension, October 1, 2008; 52(4): 737 - 746.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics